Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
1982.
SPINAL CORD COMPRESSION IN THALASSAEMIA.
The Lancet,
Vol. 319,
Issue. 8273,
p.
664.
1982.
IN DELAY THERE LIES NO PLENTY.
The Lancet,
Vol. 319,
Issue. 8273,
p.
665.
Fernbach, Sandra K.
1984.
Case report 274.
Skeletal Radiology,
Vol. 11,
Issue. 4,
p.
307.
Festa, Robert S
1985.
Modern Management of Thalassemia.
Pediatric Annals,
Vol. 14,
Issue. 9,
p.
597.
Barrati, Peter S.
and
Toogood, Ian R.G.
1987.
Hearing loss attributed to desferrioxamine in patients with beta‐thalassaemia major.
Medical Journal of Australia,
Vol. 147,
Issue. 4,
p.
177.
Albera, R.
Pia, F.
Morra, B.
Lacilla, M.
Bianco, L.
Gabutti, V.
and
Piga, A.
1988.
Hearing Loss and Desferrioxamine in Homozygous Beta-Thalassemia.
International Journal of Audiology,
Vol. 27,
Issue. 4,
p.
207.
Porter, John B.
Jaswon, Mervyn S.
Huehns, Ernst R.
East, Charles A.
and
Hazell, Jonathan W. P.
1989.
Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage.
British Journal of Haematology,
Vol. 73,
Issue. 3,
p.
403.
Porter, J.B.
and
Huehns, E.R.
1989.
11 The toxic effects of desferrioxamine.
Baillière's Clinical Haematology,
Vol. 2,
Issue. 2,
p.
459.
Papanastasiou, D A
Papanicolaou, D
Magiakou, A M
Beratis, N G
Tzebelikos, E
and
Papapetropoulos, T
1991.
Peripheral neuropathy in patients with beta-thalassaemia..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 54,
Issue. 11,
p.
997.
Sheikha, Anwar
Kameswaran, Mohan
Okafor, B. C.
and
Al-Saigh, Abdul-Aziz
1992.
Otological manifestations of thalassaemia intermedia: evidence of temporal bone involvement and report of a unique cholesteatoma-like lesion.
The Journal of Laryngology & Otology,
Vol. 106,
Issue. 4,
p.
316.
Önerci, M.
Aslan, S.
Gümrük, F.
Aksoy, S.
Belgin, E.
Özçelik, T.
and
Altay, Ċ.
1994.
Audiologic and impedancemetric findings within thalassaemic patients.
International Journal of Pediatric Otorhinolaryngology,
Vol. 28,
Issue. 2-3,
p.
167.
Kanno, Hidetaka
Yamanobe, Syu
and
Rybak, Leonard P.
1995.
The ototoxicity of deferoxamine mesylate.
American Journal of Otolaryngology,
Vol. 16,
Issue. 3,
p.
148.
Conlon, Brendan J.
Perry, Brian P.
and
Smith, David W.
1998.
Attenuation of Neomycin Ototoxicity by Iron Chelation.
The Laryngoscope,
Vol. 108,
Issue. 2,
p.
284.
Downs, C.Renée
Stuart, Andrew
and
Holbert, Donald
2000.
Distortion product otoacoustic emissions in normal-hearing children with homozygous sickle cell disease.
Journal of Communication Disorders,
Vol. 33,
Issue. 2,
p.
111.
2001.
The Thalassaemia Syndromes.
p.
733.
Walker, Letitia J.
Stuart, Andrew
and
Green, Walter B.
2004.
Outer and Middle Ear Status and Distortion Product Otoacoustic Emissions in Children With Sickle Cell Disease.
American Journal of Audiology,
Vol. 13,
Issue. 2,
p.
164.
Sawaya, Raja A.
Zahed, Laila
and
Taher, Ali
2006.
Peripheral neuropathy in thalassemia.
Annals of Saudi Medicine,
Vol. 26,
Issue. 5,
p.
358.
Lachman, Ralph S.
2007.
Taybi and Lachman's Radiology of Syndromes, Metabolic Disorders and Skeletal Dysplasias.
p.
779.
Weatherall, David J.
and
Olivieri, Nancy F.
2009.
Disorders of Hemoglobin.
p.
357.
2009.
Disorders of Hemoglobin.
p.
321.